Works matching IS 11732563 AND DT 2014 AND VI 34 AND IP 5

Results: 10

Effect of Hepatic Impairment on the Pharmacokinetics of Levomilnacipran Following a Single Oral Dose of a Levomilnacipran Extended-Release Capsule in Human Participants.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 351, doi. 10.1007/s40261-014-0182-5

By:

Chen, Laishun;
Boinpally, Ramesh;
Greenberg, William;
Wangsa, Julie;
Periclou, Antonia;
Ghahramani, Parviz

Publication type:

Article

Effect of Lacosamide on the Steady-State Pharmacokinetics of Digoxin: Results from a Phase I, Multiple-Dose, Double-Blind, Randomised, Placebo-Controlled, Crossover Trial.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 327, doi. 10.1007/s40261-014-0180-7

By:

Cawello, Willi;
Mueller-Voessing, Christa;
Andreas, Jens-Otto

Publication type:

Article

Erratum to: Effectiveness of Pregabalin as Monotherapy or Combination Therapy for Neuropathic Pain in Patients Unresponsive to Previous Treatments in a Spanish Primary Care Setting.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 371, doi. 10.1007/s40261-014-0185-2

By:

Blanco Tarrio, Emilio;
Gálvez Mateos, Rafael;
Zamorano Bayarri, Enric;
López Gómez, Vanessa;
Pérez Páramo, Maria

Publication type:

Article

Immediate Neurological Recovery Following Perispinal Etanercept Years After Brain Injury.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 361, doi. 10.1007/s40261-014-0186-1

By:

Tobinick, Edward;
Rodriguez-Romanacce, Helen;
Levine, Arthur;
Ignatowski, Tracey;
Spengler, Robert

Publication type:

Article

Pharmacokinetics of Lacosamide and Omeprazole Coadministration in Healthy Volunteers: Results from a Phase I, Randomized, Crossover Trial.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 317, doi. 10.1007/s40261-014-0177-2

By:

Cawello, Willi;
Mueller-Voessing, Christa;
Fichtner, Andreas

Publication type:

Article

Long-Term Efficacy of OROS Hydromorphone Combined with Pregabalin for Chronic Non-Cancer Neuropathic Pain.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 309, doi. 10.1007/s40261-014-0176-3

By:

Dauri, Mario;
Lazzari, Marzia;
Casali, Manuela;
Tufaro, Giuseppe;
Sabato, Elisabetta;
Sabato, Alessandro

Publication type:

Article

Erratum to: Effect of Hyaluronidase on the Pharmacokinetics of Free and Total Platinum Species after Intra-Arterial Cisplatin in Refractory Patients with Colorectal Liver Metastases.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 369, doi. 10.1007/s40261-014-0181-6

By:

Civalleri, Dario;
Esposito, Mauro;
De Cian, Franco;
Balletto, Nadia;
Mondini, Guido;
Gogioso, Luca;
Viale, Maurizio;
Vannozzi, Maria

Publication type:

Article

Retraction Note.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 367, doi. 10.1007/s40261-014-0189-y

By:

Singh, Jasbir

Publication type:

Article

Pharmacokinetic Bioequivalence Studies of a Fixed-Dose Combination of Tamsulosin and Dutasteride in Healthy Volunteers.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 335, doi. 10.1007/s40261-014-0179-0

By:

Fossler, Michael;
Collins, David;
Thompson, Meg;
Nino, Antonio;
Bianco, Joseph;
Chetty, Dushen

Publication type:

Article

Cost Effectiveness of Fesoterodine and Tolterodine for the Treatment of Overactive Bladder with Urge Urinary Incontinence in Spain and Finland.

Published in:

Clinical Drug Investigation, 2014, v. 34, n. 5, p. 297, doi. 10.1007/s40261-014-0178-1

By:

Angulo, Javier;
Valpas, Antti;
Rejas, Javier;
Linden, Kari;
Kvasz, Marion;
Snedecor, Sonya

Publication type:

Article